GSK and Spero Secure FDA Nod for First Oral Carbapenem
LONDON, United Kingdom, June 18, 2026 GSK plc and Spero Therapeutics have achieved a major milestone in the fight...
ADC AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
LONDON, United Kingdom, June 18, 2026 GSK plc and Spero Therapeutics have achieved a major milestone in the fight...
CAMBRIDGE, Mass. and SAN DIEGO, June 17, 2026 Biogen Inc. has announced a strategic agreement to acquire RayThera Inc....
LONDON, United Kingdom, June 18, 2026 LabGenius Therapeutics and LG Chem have entered into a multi-year research collaboration, option,...
INCHEON, South Korea & KIRKLAND, Quebec, Canada, June 18, 2026 Samsung Bioepis and Organon have expanded their long-standing biosimilar...
SHANGHAI, NANJING, China, and PLEASANTON, Calif., June 18, 2026 IASO Bio has achieved a major international regulatory milestone with...
INDIANAPOLIS, Ind., June 18, 2026 Elanco Animal Health Incorporated has announced plans to establish Elanco Ventures, a dedicated corporate...
SINGAPORE and SEOUL, South Korea, June 17, 2026 D&D Pharmatech and HistoIndex have announced encouraging new findings from an...
STATEN ISLAND, N.Y., June 16, 2026 Acurx Pharmaceuticals has announced the presentation of new scientific findings from its ongoing...
LANSING, Mich. and BOSTON, Mass., June 16, 2026 Niowave, Inc. and Ratio Therapeutics Inc. have entered into a strategic...
VANCOUVER, British Columbia, June 16, 2026 Optimi Health Corp. has announced the commercial production of two new standardized microdose...
